TAVT-45

Abiraterone Acetate · Tavanta Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAVT-45, covering 2024-01-16 to 2024-01-16. Get the full timeline:

Most recent: Clinical Trial Update: TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer [Phase 3]